#USA #New York #Pomerantz LLP #VYKAT XR #Soleno Therapeutics

Investor Alert: Pomerantz Law Firm's Investigation

Pomerantz LLP is currently scrutinizing potential claims for investors of Soleno Therapeutics, Inc. (NASDAQ: SLNO). This investigation seeks to determine if the company or its executives engaged in any fraudulent activities concerning their financial disclosures or business practices that may mislead investors.

On August 15, 2025, a controversial report released by Scorpion Capital stated that Soleno's primary product, Vykat XR, was excessively priced and might pose safety risks for children using it. The backlash from this report had a significant impact on Soleno's stock, causing it to fall sharply by $5.73, or 7.41%, closing at $71.63 per share on the same day.

The allegations raised in the Scorpion report have potentially serious implications for investors, emphasizing the need for heightened scrutiny regarding the company’s operational integrity and communication. Pomerantz LLP encourages those affected to reach out for further information or to join the class action pertaining to these developments.

Pomerantz is a well-established firm known for its commitment to advocacy in cases involving securities fraud and investor rights. Founded over 85 years ago by Abraham L. Pomerantz, a pioneer in the class action sphere, the firm has played a crucial role in achieving significant financial recoveries for victims of corporate wrongdoing. With offices around the globe, Pomerantz is equipped to handle complex securities litigation, making it a trusted choice for those seeking legal recourse in such matters.

In light of these circumstances, investors who believe they may have been affected are advised to connect with Danielle Peyton by email at [email protected] or via phone at 646-581-9980, ext. 7980. Joining the investigation could be an essential step for affected stakeholders to recover losses incurred as a result of the alleged fraudulent activity.

This investigation is a stark reminder of the importance of transparency in corporate communications and the vigilance necessary for investors in assessing potential risks tied to their investments. Pomerantz LLP remains dedicated to exposing securities fraud and advocating for those who have suffered because of dishonest corporate practices.

For further details or to be part of this significant legal movement, stakeholders are encouraged to visit the Pomerantz official website or contact them directly. It’s crucial to remain informed and proactive when it comes to safeguarding investment interests in a complex financial landscape.

Contact Information:
Danielle Peyton
Pomerantz LLP
Email: [email protected]
Phone: 646-581-9980 ext. 7980

Conclusion

The case concerning Soleno Therapeutics is unfolding, and its implications could extend far beyond the immediate stock impact. Remaining informed and connected with legal expertise like Pomerantz LLP can provide investors with a better chance to navigate these troubled waters effectively.